Tristel (TSTL) Competitors

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Is AMS or TSTL a better dividend stock?

Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.6%. Advanced Medical Solutions Group pays out 38.8% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Which has preferable valuation and earnings, AMS or TSTL?

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£132.18M	3.28	£11.22M	£5.16	38.95
Tristel	£42.24M	4.13	£6.54M	£13.66	26.71

Do institutionals and insiders hold more shares of AMS or TSTL?

58.2% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 3.1% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 4.9% of Tristel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, AMS or TSTL?

Advanced Medical Solutions Group has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500.

Is AMS or TSTL more profitable?

Tristel has a net margin of 15.47% compared to Advanced Medical Solutions Group's net margin of 8.49%. Tristel's return on equity of 20.43% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	8.49%	4.57%	2.35%
Tristel	15.47%	20.43%	9.89%

Do analysts prefer AMS or TSTL?

Advanced Medical Solutions Group currently has a consensus target price of GBX 287.50, suggesting a potential upside of 43.03%. Tristel has a consensus target price of GBX 400, suggesting a potential upside of 9.59%. Given Advanced Medical Solutions Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media refer more to AMS or TSTL?

In the previous week, Advanced Medical Solutions Group's average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company	Overall Sentiment
Advanced Medical Solutions Group	Neutral
Tristel	Neutral

Summary

Advanced Medical Solutions Group beats Tristel on 9 of the 16 factors compared between the two stocks.